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T cell activation is invariably associated with virus infections, but activation of T cells is also noted, for example, in patients
with persistent bacterial infections with intracellular pathogens or localised bacterial bioﬁlms. The latter is characterised by a
destructive inﬂammatory process. Massive inﬁltration of leukocytes, predominantly of polymorphonuclear neutrophils (PMNs)
and of T lymphocytes, is seen. While PMN inﬂux into sites of bacterial infection is in line with their role as “ﬁrst-line defence” a
role of T cells in bacterial infection has not yet been delineated. We now found evidence for activation and expansion of peripheral
blood T cells and an upregulation of Toll-like receptors 1, 2, and 4 on small portions of T cells. T cells recovered from the infected
site were terminally diﬀerentiated and produced interferon gamma, a cytokine known to enhance functions of phagocytic cells,
leading to the conclusion that inﬁltrated T cells support the local immuner defence.
1.Introduction
Activation and expansion of T lymphocytes is invariably
associated with the immune response to virus infection,
and the clearance of virus-infected cells. Activation of T
cells, however, is also seen in bacterial infection, particularly
in those caused by intracellular bacteria [1, 2] and—as
we showed recently—in patients with implant-associated
osteomyelitis, a prototype of a bioﬁlm infection [3, 4].
Bacterialbioﬁlmsareincreasinglyrecognisedasthecause
for persistent and destructive inﬂammatory processes [5, 6].
According to Donlan and Costerton [7], bioﬁlms are deﬁned
as “microbial derived sessile communities characterised by
cellsthatareirreversiblyattachedtoasubstratumorinterface
or to each other, embedded in a matrix of extracellular
polymeric substances that they have produced, and exhibit
an altered phenotype with respect to growth rate and
gene transcription.” It is generally assumed that bacteria in
bioﬁlms escape the host defence. In vitro data suggest that
bacteria in bioﬁlms as not as susceptible to the phagocytic
eﬀector functions as their planktonic living counterparts [8,
9]; there is, however, no doubt that bioﬁlms are not entirely
protected [10] and that bioﬁlm infection elicit an activation
of the immune response with an inﬁltration into the infected
site of leukocytes, predominantly of polymorphonuclear
neutrophils (PMNs) and T lymphocytes [3, 4, 11–13].
While the participation of PMN in the defence against
bacterial infection and in the acute inﬂammatory response
is well understood, a role for T cells has not yet been
delineated, nor is it known how T cells recognise bacteria.
In that context, the aim of the present study was to
analyse T cells of patients with persistent bacterial infections2 International Journal of Inﬂammation
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Figure 1: Expression of CD11b and CD28 on CD4+ T cells of patients with implant-associated osteomyelitis and of healthy donors:
(a) by cytoﬂuorometry expression of CD11b and CD28 were determined. The gate was set for CD4+ cells. With regard to CD11b and
CD28 expressions, four populations were detected: CD28+CD11b-, CD28+CD11b+, CD28-CD11b-, and CD28-CD11b+ (an example for
a patient and a donor is shown in (a) (The numbers give the percentage of CD4+ found in the respective quadrant.) (b) The percentage of
CD4+CD11b+ in the patients (n = 28) and the donors (n = 18) is shown. The horizontal bar indicates the median value. The mean values
for the patients (mean ± SD 5.6 ± 5.3%) diﬀered signiﬁcantly from that obtained for the donors (2.2 ± 2.4%) as calculated by ANOVA
(P = .015).
with regard to expression of activation-associated receptors
on T cells, particularly of Toll-like receptors (TLRs) on.
TLRs recognise conserved microbial structures including
lipopolysaccharides (LPSs), lipoteichoic acid (LTA), lipopep-
tides, or bacterial DNA and RNA. As the so-called “pattern
recognition receptors” TLRs are primarily studied on cells
of the innate immune response; however, TLR are also
detectedonTcells,andamodulatoryfunctionofthespeciﬁc,
adaptive immune response via TLRs is presumed [14–17].
We focussed on TLR1, TLR2, and TLR4, because these
receptors alone or in combination recognise the bacterial
products LTA or LPS which might be present at the site
of infection. Moreover, to further characterise T cells we
determined surface receptors known to be associated with
activation, such as CD11b and CD57, as well as production
of interferon gamma, a cytokine known for its capacity to
activate phagocytic cells.
2. Patients, Material,and Methods
2.1. Patients and Donors. After having obtained informed
consent and after approval by the local ethic committee, 38
patientswithimplant-associatedinfectionsrequiringsurgery
for removal of the implant or the endoprosthesis were
recruited into the study between 1/2004 and 5/2007. The
diagnosis was based on the medical history, the clinical
examination, and X-rays. In the majority of patients, the
leukocyte count was within the normal range (5 to 10 ×
103/μL); leukocytosis was seen in 8 patients. The C-reactive
protein (CRP) serum concentrations were enhanced in 34
patients. The patients diﬀered with regard to age (23 and
84years), sex, localisation of the implant/endoprosthesis,
and the interval between the primary implantation and
the development of the clinically apparent osteomyelitis (2
months to 5years). Intraoperatively, in all patients a promi-
nent leukocyte inﬁltration and pus formation was observed,
conﬁrming the diagnosis of osteomyelitis. From all patients
swabs were taken intraoperatively for the identiﬁcation of
bacteria with the following results: Staphylococcus aureus
(n = 12); S. epidermidis (n = 7), Streptococci (n = 3), E. coli
(n = 1), and propionibacter (n = 1). One patient presented
with Candida albicans, and in 12 patients no bacteria were
identiﬁed. The failure to detect bacteria by conventional
diagnostic methods, however, does not rule out infection,
since it is known that in implant-associated infection
bacteria tend to form bioﬁlms. Due to this specialised life-
form, the bacteria do not grow as rapidly as their free-
swimmingplanktoniccounterpartsandthereforemayescape
detection.
From the patients, venous blood (5mL) was taken
immediately prior to surgery. For comparison, blood of
healthy donors (n = 20) was taken (informed consent was
obtained and the institutional guidelines were observed).
Because some of the parameters, particularly expression of
CD28 and CD57 increased with age, the donors were age
matched. The cytoﬂuorometric studies (see below) were
carried out within 3hours after blood withdrawal. Of note,
for technical reasons, speciﬁally the limited number of cells,International Journal of Inﬂammation 3
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Figure 2: Continued.4 International Journal of Inﬂammation
C
D
2
8
p
o
s
C
D
1
1
b
n
e
g
C
D
2
8
p
o
s
C
D
1
1
b
p
o
s
C
D
2
8
n
e
g
C
D
1
1
b
p
o
s
C
D
2
8
p
o
s
C
D
1
1
b
n
e
g
C
D
2
8
p
o
s
C
D
1
1
b
p
o
s
C
D
2
8
n
e
g
C
D
1
1
b
p
o
s
C
D
2
8
p
o
s
C
D
1
1
b
n
e
g
C
D
2
8
p
o
s
C
D
1
1
b
p
o
s
C
D
2
8
n
e
g
C
D
1
1
b
p
o
s
0
20
40
60
C
D
4
+
T
L
R
1
+
(
%
)
80
100
0
20
40
60
C
D
4
+
T
L
R
2
+
(
%
)
80
100
0
20
40
60
80
100
C
D
4
+
T
L
R
4
+
(
%
)
(c)
Figure 2: Expression of TLR on peripheral CD4+ T cells in patients with implant-associated osteomyelitis and healthy donors: (a) by
cytoﬂuorometry, expression of TLR1, TLR2, and TLR4 on CD4+ cells was determined. Each dot represents a patient or a donor, respectively.
The horizontal bars represent the mean values. These were diﬀerent between patients and donors as calculated by ANOVA. (b) When the
gate (P2) was set for CD4+ cells, TLR positive cells could be identiﬁed (P3) (middle panel) and the expression of CD28 and CD11b on these
cells could be determined (right panel). Four cell populations became apparent CD28-CD11b+ (Q1), CD28+CD11b+ (Q2), CD28-CD11b-
(Q3), and CD28+CD11b- (Q4). The markers to determine positive or negative were set according to the isotype controls (not shown). The
numbers refer to the percentage of cells in the respective quadrant and are calculated as per cent of TLR positive cells. In (b) an example for
a single patient is shown, in (c) data of 10 patients and 9 donors are summarised in box and whiskers plots, with the horizontal bar showing
the median, and the dot showing the mean values. (Again, markers to deﬁnes positive or negative were set according to the appropriate
isotype control.)
notallexperimentswerecarriedwithcellsofallpatients.The
actual number of patients for one particularly parameter is
given in the respective ﬁgure legend.
2.2. Recovery of the Leukocytes from the Infected Site.
During surgery the tissue surrounding the infected
implant/endoprosthesis was rinsed with 50 to 100mL
of sterile pyrogene-free 0.9% saline using a 50mL syringe.
The so-called “lavage” was collected in sterile tubes
containing heparin (2500IU per 50mL) and sodium azide
(ﬁnal concentration 0.1%). The samples were processed
within 3 hours. The cells were collected by centrifugation
(10min; 1500rpm), washed with sterile phosphate buﬀered
saline (PBS) containing 0.1% bovine serum albumin, and
subjected to cytoﬂuorometry. Between 5 × 105 to 107
leukocytes could be harvested.
2.3. Cytoﬂuorometry. Labelling of cells was performed using
the following antibodies: FITC-labelled antibody to CD57
(Becton Dickinson Biosciences Pharmingen; Heidelberg,
Germany); allophycocyanin (APC)-labelled antibody to
CD4 (Becton Dickinson); APC-labelled isotypic mouse
IgG1 (Becton Dickinson); PE-labelled antibody to CD28
(Clone 28.1; DakoCytomation; Glostrup, Denmark); FITC-
labelled antibody to CD11b (Biozol); FITC-labelled iso-
typic mouse IgG1 (Immunotech; Marseille, France); APC-
labelled antibody to CD8 (BD Biosciences Pharmingen); PE-
labelled antibody to CD8 (Becton Dickinson); CyChrome-
labelled antibody to CD56 (BD Biosciences Pharmin-
gen); CyChrome-labelled isotypic mouse IgG1 (Becton
Dickinson); phycoerythrin (PE)-labelled anti-mouse IgG2a
(Biozol; Eching, Germany); PE-labelled antibody to CD4
(Immunotech); FITC- and Phycoerythrin (PE)-labelled iso-
typic mouse IgG1/IgG2a (Immunotech). PE-conjugated
antibodies to Toll-like receptors (eBioscience SanDiego,
USA). The ﬁnal concentration of antibodies varied between
1–20μg/mL of whole blood. Following incubation with
the respective antibodies (20 minutes, room temperature),
erythrocytes were lysed using FACS-lyzing solution provided
by Becton Dickinson. Cells were analyzed by FACSCalibur
and CellQuest software (Becton Dickinson). Results are
expressed as percentage positive cells in the respective gate
or quadrant. The markers were set according to the IgG
isotype controls. Cells of the lavage were washed in PBSInternational Journal of Inﬂammation 5
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Figure 3: Assessment of linear correlations of TLR expression: TLR
expression on CD4+ cells (values represent % TLR1, TLR2 or TLR4
positive CD4+ cells; each dot represents one patient) was plotted
andbylinearﬁtanalysisthecorrelationwasassessed.WithP<. 001,
a weak correlation between TLR1 and TLR4 expression was seen,
and between TLR2 and TLR4 expression, but not between TLR1
and TLR2.
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Figure 4: Presence of TLR positive cells in the peripheral blood
of patients correlates with infection: CD4+CD28+CD11b+TLR1+,
CD4+CD28+CD11b+TLR2, or CD4+CD28+CD11b+TLR4 was
quantiﬁed by cytoﬂuorometry at the day of surgery (before) or 6
to 8 days later (after), when the infection was resolved. Each symbol
refers to an individual patient; the line connects the values before
and after surgery.
containing 1% bovine serum albumin and 0.1% sodium
azide, adjusted to 106/100μL and incubated with the respec-
tive antibodies (1μg/100μL). For intracellular staining, the
cells were permeabilised using FACS/Perm solution and the
protocol provided by Becton and Dickinson. The FITC-
labelled antibody to interferon γ was purchased from Serotec
(D¨ usseldorf, Germany).
Statistics. Data are presented as box and whiskers blots, with
the box containing 50% of the measured values, the whiskers
showing the highest and the lowest values, respectively, the
horizontal bar the median values and the square the mean
values. The diﬀerences between the mean values of the
groups (cells from the patients versus cell of the healthy
donors) were calculated using ANOVA.
3. Results
3.1. Evidence for the Activation of CD4+ T Cells in the
Peripheral Blood of Patients with Implant-Associated
Osteomyelitis
3.1.1. Up-Regulation of CD11b and Loss of CD28. Loss of
CD28 and up-regulation of CD11b is associated with acti-
vation and expansion of T cells clones. To assess activation
of T cells we determined these receptors on CD4+ T cells of
patients with implant-associated osteomyelitis immediately
before surgery. By cytoﬂuorometry four cell populations
could be determined: CD28+CD11b−, CD28+CD11b+,
CD28−CD11b+, and CD28−CD11b−. T cells expressing
CD11b were found in the majority of patients, and to a lesser
extent in the healthy donors. Within the CD4+CD11b+
population, CD28− were prevalent (60 ± 17%) (example
and summary of data in Figures 1(a) and 1(b)). That6 International Journal of Inﬂammation
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Figure 5: Expression of TLR on peripheral CD8+ cells in patients with implant-associated osteomyelitis and in healthy donors: (a) by
cytoﬂuorometry,expressionsofTLR1,TLR2,andTLR4onCD8+cellswasdetermined.Eachdotrepresentsapatientoradonor,respectively.
The horizontal bars represent the median values. The mean values for TLR2 and TLR4 were diﬀerent between patients and donors as
calculated by ANOVA. (b) CD8+CD28+CD11b+ expressing TLR1, TLR2, or TLR4 were quantiﬁed by cytoﬂuorometry at the day of surgery
(before) or 6 to 8 days later (after) when the infection was resolved. Each symbol refers to an individual patient; the line connects the values
before and after surgery.
CD11b was preferentially associated with the CD28- cells
is in line with the fact that CD4+CD28+CD11b+ represent
an early transient phenotype, as opposed to the activated
CD4+CD28−CD11b+ phenotype.
3.1.2. Expression of Toll-Like Receptors. In the peripheral
bloodofhealthydonors,lessthan1%ofTcellsexpressTLR1,
TLR2, or TLR4. In the majority of patients with implant-
associated osteomyelitis, however, T cells expressing TLR1,
TLR2 or TLR4 were detected. A preferential association
of TLR1 and TLR2 expressions with CD4+CD28−CD11b+
cells was seen, compatible with the fact these cells represent
an activated phenotype (data summarised in Figure 2).
3.1.3. Association of T Cell Activation with the Infection.
We did not ﬁnd correlations between the percentage of
CD4+CD11b+orTLRpositivecellswiththeclassicalinﬂam-
matory parameters including serum CRP concentrations or
leukocyte count; there was, however, a weak correlation
between TLR1–TLR4, and TLR2–TLR4 expressions, but not
between TLR1–TLR2 (Figure 3). From six patients we were
able to test the peripheral blood cells after recovery (6
to 8 days after surgery). The percentage of CD4+CD11b+
and CD4+CD28− cells declined, as did the population of
CD4+CD28+CD11b+TLR+ (Figure 4).
3.2. Analysis of Peripheral CD8+ Cells: Expression of CD11b,
CD28,andTLR. WhenmeasuringCD28andCD11bexpres-
sion on CD8+ cells, no major diﬀerences between donors
and patients were seen. On average, 28.5 ± 14.1% of the
patients’ CD8+ cells expressed CD11b versus 29.21 ± 14.7%
of donors’ cells, and 43.4 ± 22.9% were CD28 negative
compared to 37.4 ± 20.3% in the donors (patients n =
28; donors n = 18). CD11b was predominantly seen
on CD28− cells. Thus, when compared as a group no
importantdiﬀerenceswereseenbetweenpatientsanddonors
regarding CD28 and CD11b expressions. Small populations
(3 to 5%) of CD8+ T cells expressing TLR2 and TLR4
were found in the majority of the patients, and to a lesser
extent in healthy donors (Figure 5(a)). TLR expression was
seen predominantly on CD11b+ cells. After recovery of the
patients the percentage of CD8+CD28+CD11b+TLR+ cells
declined, which was particularly obvious when compared
within the same patient (Figure 5(b)).
3.3. Characterisation of the Inﬁltrated T Cells. As reported
before, CD4+ and CD8+ T cells were found at the infected
site, with a shift towards CD8+ when compared to the
peripheral blood of the same donor [3]. For CD4+ cells,
an accumulation of CD11b+ and CD28− was seen, which
was particularly noticable when compared within the same
patient (Figures 6(a) and 6(b)). Again, for CD8+ the
data were less convincing; in some patients the percentage
of transiently activated CD8+CD28+CD11b+ phenotype
was slightly higher at the infected site. In all, however,
an accumulation CD8+CD57+ was seen. CD57 expression
identiﬁes terminally diﬀerentiated of CD8+ eﬀector (Figures
6(c)and6(d)).TheexpressionpatternoftheTLRwassimilar
to that of the peripheral blood T cells, and an important
accumulation at the infected site of TLR positive cells was
not obvious.
3.4. Synthesis of Interferon γ by Peripheral and Inﬁltrated T
Cells. To determine synthesis of interferon γ, the inﬁltrated
leukocytes, and for comparison the cells in whole peripheralInternational Journal of Inﬂammation 7
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Figure 6: Characterisation of the inﬁltrated T cells: (a,b) compared to the peripheral blood, the cellular inﬁltrate (local) contained a higher
percentage of CD4+CD11b+ cells, while CD28− was lost (each pair of symbols corresponds to one patient). (c) For CD8+ cells, a small
increase of CD8+CD11b+ cells in the cellular inﬁltrate was seen in the majority of patients, and (d) a considerable in increase in CD8+
expressing CD57.
blood, were incubated for 4 to 16hours in the presence of
brefeldin 1 in order to allow accumulation of the cytokine in
the cells. Interferon γ was then detected by cytoﬂuorometry
of the permeabilised cells. We found in the inﬁltrated T cells,
but not in the peripheral blood T cells, interferon γ in up to
50% of the cells (Figure 7).
4. Discussion
Our data provide evidence for the activation and expansion
of T cells in patients with persistent bacterial infection. As
marker for activation we measured expression of CD11b,
because this adhesion protein is associated with T cell
activation [18–20] and thought to be a homing receptor
of T lymphocytes for nonlymphoid tissue [21]s u c ha sa n
infected or inﬂamed site. In our patients, CD11b expression
was particularly obvious on CD4+ T cells—quite in contrast
to the situation in virus-infected patients, where CD8+ cells
acquired CD11b [22]. CD11b expression was seen mainly on
CD4+ cells that had lost CD28, in line with numerous in
vitro studies which showed that activation and expansion of
CD4+ cells is associated with a loss of CD28 [23]. That only8 International Journal of Inﬂammation
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Figure 7: Synthesis of interferon γ by the inﬁltrated T cells. (a) The inﬁltrated T cells were recovered and cultured for 16hours in the
presence of brefeldin 1. The cells were permeabilised, and interferon γ was determined by cytoﬂuorometry, as was CD4 and CD8. The gate
was set for CD4+ or CD8+, respectively. Up to 90% of cells contained interferon γ. (b) Data of 7 patients are summarised. Shown are values
obtained for the inﬁltrated T cells (local), for T cells of the peripheral blood of patients, and for healthy donors as well (diﬀerences of the
mean values were calculated by ANOVA and found to be diﬀerent with a P<. 001).
a minor portion of CD4+ cells acquires CD11b is in line with
a no l i g o c l o n a lC D 4 +Tc e l la c t i v a t i o n ,a si ti se x p e c t e df o ra n
antigen-drivenTcellactivation.Ofnote,afterrecoveryofthe
patients, the percentage of CD4+CD11b+ and CD4+CD28−
declined,indicativeofacausalrelationshipbetweeninfection
and T cell activation.
When analysing the CD8+ cells, the data were less
clear-cut: no major diﬀerences between patients and donors
were seen when comparing the percentage of CD8+CD28−
cells or CD8+CD11b+ cells. The most likely explanation
is that CD8+CD28− cells, in contrast to CD4+CD28−
cells, persist following activation and form the pool
of CD8+CD28−CD11b+ and CD8+CD28−CD11b− cells
which increases with age and antigen contact [23–26].
Thus, smaller changes induced by an ongoing oligoclonal T
cell activation might be obliterated. Only when compared
within the same patient, CD8 activation became apparent:
CD8+CD28+CD11b+ which represent a transiently acti-
vated T cell phenotype [3, 22] were found in small numbers
in the patients, and disappeared within days after surgery
(compare Figure 5).
Another new aspect of our study concerned the expres-
sion of TLR. As pattern recognition receptors, TLR expres-
sion is predominantly studied on cells of the innate immune
system. There is, however, also evidence for TLR expression
on T cells. Moreover, numerous in vitro studies showed that
engagement of TLR by their respective ligands modulate T
cell activity, including up-regulation of interferonγ synthesis
[14–17]. We found in the majority of patients CD4+ and
CD8+ cells expressing of TLR, particularly TLR2, a receptor
selective for lipoteichoic acid, a major component of the
outer cell wall of Gram-positive bacteria. The association
of the TLR with activated T cells, those having lost CD28
and expressing CD11b, suggests a role for TLR in the bac-
terial infection-induced T cell response. That preferentially
TLR2 is up-regulated in line with the observation that
in our patients infection with Gram-positive bacteria is
prevalent.International Journal of Inﬂammation 9
Further evidence for T cell activation in the context of
bacterial infection is their inﬁltration into the infected site.
As reported before, 10 to 30% of the inﬁltrated leukocytes
wereidentiﬁedasTcells.Both,CD4+andCD8+werefound,
with—asreportedpreviously[3]—apredominanceofCD8+
Te ﬀector cells. For CD4+ cells, there was evidence for an
accumulationparticularlyofactivatedCD28−CD11b+cells,
in line with observation that CD11b might be a homing
receptor directing activated T cells to nonlymphoid tissue
[21]; whereas for CD8+ T cells we found an accumulation
of cells expressing CD57, a receptor typical for terminally
diﬀerentiated eﬀector cells [27].
Given the fact that T cells are activated in the course of
bacterialinfectionandinﬁltratetheaﬀectedsite,thequestion
arises whether or not they participate in the local immune
defence. Terminally diﬀerentiated T cells are a rich source
of numerous cytokines, and in our patients up to 90% of
the inﬁltrated T cells synthesised interferon γ,a p p a r e n ta sa n
accumulation of the cytokine within the cells. Interferon γ is
a potent activator of phagocytic cells. It prevents apoptosis of
PMN and enhances their phagocytic and bactericidal activity
[28, 29] and thus could support the local host defence.
We have, so far, only indirect evidence for the function of
interferon γ at the infected site. Inﬁltrated PMN express
MHC class II antigens [30], which on PMN are exclusively
up-regulated by T cell-derived cytokines or by direct contact
with activated T cells [31, 32]. Whether inﬁltrated T cells
indeed contribute to the local host defence remains to be
shown; it is, however, an attractive hypothesis.
In conclusion our data provide evidence that in response
to local, persistent bacterial infections T cells are activated
and recruited to the inﬂammatory site. The up-regulation of
Toll-like receptors could provide the T cells with means to
sense the “danger” of bacterial infection.
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